Histamine Receptors

Shop By

Items 1-50 of 58

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Product Citation
  1. H1 antagonist

    Asenapine shows high affinity (pKi) for numerous receptors, including the serotonin 5-HT1A (8.6), 5-HT1B (8.4), 5-HT2A (10.2), 5-HT2B (9.8), 5-HT2C (10.5), 5-HT5A (8.8), 5-HT6 (9.5), and 5-HT7 (9.9) receptors, the adrenergic α1 (8.9), α2A (8.9), α2B (9.5), and α2C (8.9) receptors, the dopamine D1 (8.9), D2 (8.9), D3 (9.4), and D4 (9.0) receptors, and the histamine H1 (9.0) and H2 (8.2) receptors.
  2. H2-receptor antagonist

    Cimetidine is a histamine H2-receptor antagonist that inhibits stomach acid production.
  3. Histamine Receptor antagonis

    Clemastine is a selective histamine H1 antagonist. It binds to the histamine H1 receptor, thus blocking the action of endogenous histamine, which leads to temporary relief of the negative symptoms caused by histamine.
  4. H3-receptor antagonist

    Ciproxifan maleate is a potent, selective H3 histamine receptor antagonist.
  5. Histamine Receptor antagonist

    Bepotastine Beslilate (Bepreve) is a histamine H1 receptor anatagonist.
  6. histamine receptor antagonist

    Cyproheptadine hydrochloride is a histamine receptor antagonist for 5-HT2 receptor with IC50 of 0.6 nM.
  7. NMDA receptor antagonist

    Orphenadrine citrate is a NMDA receptor antagonist with Ki of 6.0 +/- 0.7 μM, HERG potassium channel blocker.
  8. H2 receptor antagonist

    Lafutidine is a second generation H2 receptor antagonist having multimodal mechanism of action.
  9. Histamine Antagonist

    JNJ7777120 is a potent, selective non-imidazole H4?histamine receptor antagonist.
  10. H1 histamine receptor antagonist.

    Clemizole is an H1 histamine receptor antagonist.
  11. Histamine H2-receptor antagonist

    Metiamide is a histamine H2-receptor antagonist developed from another H2 antagonist, burimamide. It was an intermediate compound in the development of the successful anti-ulcer drug cimetidine.
  12. Histamine H4 receptor antagonist

    A 943931 2HCl is a potent and selective histamine H4 receptor antagonist (pKi values are 7.15 and 8.12 at human and rat receptors respectively).
  13. H1-receptor antagonist

    Astemizole is a potent antihistamine (H1-receptor antagonist, IC50 = 4 nM) that displays selectivity over dopamine, 5-HT, and muscarinic acetylcholine receptors. This compound has shown potent hERG K+ channel blocking activity (IC50 = 0.9 nM), antimalarial activity in multidrug resistant strains in vitro (IC50 = 227 - 734 nM), and has been used as a chaperone to correct folding defects and restore protein function for some mutated forms of hERG channels.
  14. H3R antagonist/TRPV1 antagonist

    ABT-239 is a novel, highly efficacious, non-imidazole class of H3R antagonist and a transient receptor potential vanilloid type 1 (TRPV1) antagonist.
  15. Histamine H1 receptor antagonist

    Promethazine HCl is a potent histamine H1 receptor antagonist.
  16. H1-histamine receptor antagonist

    Ebastine is a H1 antihistamine with low potential for causing drowsiness.
  17. H3 receptor antagonist

    Bavisant dihydrochloride is a highly selective, orally active antagonist of the human H3 receptor with a novel mechanism of action, involving wakefulness and cognition, with potential as a treatment for ADHD.
  18. H3 receptor antagonist

    Bavisant dihydrochloride hydrate is a highly selective, orally active antagonist of the human H3 receptor with a novel mechanism of action, involving wakefulness and cognition, with potential as a treatment for ADHD.
  19. H1-receptor antagonist

    Cetirizine, a second-generation antihistamine, is a major metabolite of hydroxyzine, and a racemic selective H1 receptor inverse agonist used in the treatment of allergies, hay fever, angioedema, and urticaria.
  20. H1 histamine receptor antagonist

    Clemizole hydrochloride is an antagonist of H1 histamine receptor with an IC50 value of 8 mM for NS4B RNA binding.
  21. H2-receptor antagonist

    Ebrotidine is a competitive H2-receptor antagonist (Ki= 127.5 nM) with a potent antisecretory activity and evidenced gastroprotection.
  22. H2-receptor antagonist

    Zaltidine is a H2-receptor antagonist, which has the antisecretory action.
  23. serotonin/histamine2 antagonist

    Cyproheptadine hydrochloride sesquihydrate is an antihistamine and is an antagonist of serotonin and histamine2.
  24. H1 histamine receptor antagonist

    Alcaftadine is a high affinity ligand for the H1 receptor, with a pKi (8.5) that is comparable with that of other H1 antihistamines. Alcaftadine is also an antagonist for H2 and H4 receptors with no affinity for the H3 receptor.
  25. Histamine H1 receptor antagonist

    Cyclizine 2HCl is a piperazine derivative with Histamine H1 receptor antagonist activity.
  26. H1-receptor antagonist

    Tripelennamine hydrochloride, a H1-receptor antagonist, is a psychoactive drug and member of the pyridine andethylenediamine classes that is used as an antipruritic and first-generation antihistamine.
  27. H4 receptor antagonist

    JNJ-39758979 is histamine H4 receptor antagonists with a Ki of 12.5 nM.
  28. H1 histamine receptor antagonist

    Terfenadine ((??)-Terfenadine) is a potent open-channel blocker of hERG with an IC50 of 204 nM. Terfenadine, an H1 histamine receptor antagonist, acts as a potent apoptosis inducer in melanoma cells through modulation of Ca2+ homeostasis. Terfenadine induces ROS-dependent apoptosis, simultaneously activates Caspase-4, -2, -9 and induces p73, Noxa.
  29. Histamine H1 receptor antagonist

    Levocetirizine dihydrochloride is a L-isomer of cetirizine and histamine H1 receptor antagonist. It incrases levels of CD4+ CD25+ T cells and decreases levels of eosinophils, decreasing allergy symptoms.
  30. histamine H1 receptor antagonist

    Emedastine Difumarate is the difumarate salt form of emedastine, a second generation, selective histamine H1 receptor antagonist with anti-allergic activity. This medication is an antihistamine, prescribed for allergic conjunctivitis.
  31. Histamine H1 receptor antagonist

    Hydroxyzine pamoate is an histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness.
  32. Histamine H2-receptor antagonist

    Ranitidine is a potent, selective and orally active histamine H2-receptor antagonist with an IC50 of 3.3 μM that inhibits gastric secretion.
  33. Histamine 1 receptor antagonist

    Acrivastine (BW825C) is a short acting histamine 1 receptor antagonist for the treatment of allergic rhinitis.
  34. hemagglutinin (HA)-receptor antagonist

    Alimemazine hemitartrate is a phenothiazine derivative that is generally used as an antipruritic agent and also a hemagglutinin (HA)-receptor antagonist.
  35. histamine H1-receptor antagonist

    Diazoline is a histamine H1-receptor antagonist.
  36. histamine H1 antagonist

    Chlorcyclizine hydrochloride is a histamine H1 antagonist.
  37. Histamine H1 antagonist

    Mequitazine is a potent histamine H1 antagonist or antihistamine. It competes with histamine for the normal H1-receptor sites on effector cells of the gastrointestinal tract, blood vessels and respiratory tract.
  38. nonsedating H1 antagonist

    Rocastine is a selective, nonsedating H1 antagonist, acting as an antihistamine.
  39. histamine H1 receptor antagonist

    ReN 1869 hydrochloride is a novel, selective histamine H1 receptor antagonist, which demonstrates affinity to the histamine H1 receptor (guinea pig brain) with Ki of 0.19±0.04 μM and the non-selective ?? site (guinea pig brain) with Ki of 0.45 μM.
  40. H4R antagonist

    H4R antagonist 1 is a potent and highly selective histamine H4 receptor (H4R) antagonist with an IC50 of 27 nM.
  41. H3 receptor antagonist

    S 38093 is a brain-penetrant antagonist of H3 receptor, with Ki of 8.8, 1.44 and 1.2 ?M for rat, mouse and human H3 receptors, respectively.
  42. histamine H3 receptor antagonist

    Cipralisant is a potent and selective histamine H3 receptor antagonist in vivo, and an agonist in vitro, with a pKi of 9.9 for histamine H3 receptor and a Ki of 0.47 nM for rat histamine H3 receptor; Cipralisant has entered in clinical trials for the treatment of attention-deficit hyperactivity disorder.
  43. H1 receptor antagonist

    Wy 49051 is a potent, orally active H1 receptor antagonist, with IC50 of 44 nM.
  44. histamine H1 receptor antagonist

    Pirolate is a histamine H1 receptor antagonist.

  45. histamine H2-receptor antagonist

    CP-66948 is a histamine H2-receptor antagonist with gastric antisecretory activity and mucosal protective properties.
  46. histamine H2 receptor antagonist

    BMY-25271 is a histamine H2 receptor antagonist.
  47. histamine 1 receptor antagonist

    Decloxizine(UCB-1402; NSC289116) is a histamine 1 receptor antagonist.
  48. histamine H4 receptor antagonist

    Toreforant is a potent and selective histamine H4 receptor (H4R) antagonist, with a Ki at the human receptor of 8.4 nM.
  49. human H3 receptor antagonist

    Bavisant (JNJ-31001074) is a highly selective, orally active antagonist of the human H3 receptor with a novel mechanism of action, involving wakefulness and cognition, with potential as a treatment for ADHD.
  50. histamine H3 receptor antagonist

    PF-03654746 is a potent and selective histamine H3 receptor antagonist with high brain penetration.

Items 1-50 of 58

Page
per page
Set Descending Direction